CIK 0001628171
- Large accelerated filer
Revolution Medicines, Inc.
Sign in to watch- Ticker
- RVMD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472029180
- Phone
- +1 650-481-6801
- Business address
- 700 SAGINAW DR, REDWOOD CITY, CA, 94063
Securities
- RVMD Common Stock Nasdaq
- RVMDW Warrant Nasdaq
- 4 Planned sale Mancini Anthony sold 3,120 shares at an average $132.41 ($413,129)
- 4 Planned sale GOLDSMITH MARK A sold 120,000 shares at $150.09 ($18,010,488)
- 4 Planned sale Mancini Anthony sold 37,450 shares at an average $95.56 ($3,578,821)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Medical Officer sold 2,073 shares at $99.48 ($206,223)
- 4 Planned sale Kelsey Stephen Michael sold 4,302 shares at $99.48 ($427,965)
- 4 Planned sale GOLDSMITH MARK A sold 12,871 shares at $99.48 ($1,280,412)
- 4 Planned sale Chief Operating Officer sold 4,583 shares at $99.48 ($455,919)
- 4 Planned sale Chief Financial Officer sold 2,753 shares at $99.48 ($273,870)
- 4 Planned sale General Counsel sold 2,958 shares at an average $98.68 ($291,890)
- 4 Planned sale Wang Xiaolin sold 2,010 shares at $99.48 ($199,956)
- 4 Gift Director gave 15,000 shares (gift)
- 4 Grant or award Wang Xiaolin acquired 15,100 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 15,100 shares (grant or award)
- 4 Grant or award Kelsey Stephen Michael acquired 21,100 shares (grant or award)
- 4 Planned sale GOLDSMITH MARK A sold 36,000 shares at an average $101.23 ($3,644,354)
- 4 Grant or award Chief Operating Officer acquired 21,100 shares (grant or award)
- 4 Grant or award General Counsel acquired 14,500 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 20,200 shares (grant or award)
Page 3 of 21 · 413 filings